Introduction
Diabetes results from insufficient insulin signaling in response to blood glucose. Islet cell replacement therapy promises a future restoration of normal glycemic control in diabetic patients. Although cadaveric islet cell transplantation is currently possible, the scarcity of human donors has highlighted the need of an unlimited islet cell source. Promising findings highlight the possibility of converting adult cells into islet cells via somatic cell reprogramming (Zhou et al., 2008) , or alternatively directing the differentiation of pluripotent embryonic stem (ES) cells to islet cells (D'Amour et al., 2006) . Whether the objective is to create replacement cells in-vivo or ex-vivo, the methodology relies on our current understanding of the formation and patterning of the pancreas during embryogenesis.
Genetic studies in mice have provided evidence that all endocrine cells in the pancreas are formed from a progenitor cell that has expressed the gene Ngn3 (Gradwohl et al., 2000) . Ngn3 in the mouse has a temporal expression pattern that increases from embryonic day 9.5 (E9.5) and culminates at E13.5-14.5 where after expression decreases and approaches undetectable levels at birth (Gradwohl et al., 2000; Schwitzgebel et al., 2000) . A number of experimental evidence attests to the pro-endocrine effects of Ngn3. During directed differentiation of human embryonic stem cells, NGN3 is expressed prior to the detection of hormone-positive cells (D'Amour et al., 2006) and introduction of Ngn3 in mouse ES cells enhanced endocrine cell formation (Treff et al., 2006) . Ngn3 expression can be reactivated following partial pancreatectomy (Li et al., 2010) and in duct-ligated adult mouse pancreas. In the duct-ligated model, Ngn3-expressing cells can be traced from adult pancreatic epithelial cells, purified, and observed to adopt an endocrine cell fate including insulinproducing beta-cells (Xu et al., 2008) . Additional pro-endocrine effects of Ngn3 was observed in virus-mediated gene delivery to pancreatic ductal cells (Noguchi et al., 2006; Heremans et al., 2002) , and in the liver when Ngn3 is coordinately expressed with Pdx1 (Yoon, 2007) . Ngn3 is therefore capable of partially inducing an endocrine program in hepatic progenitors (Yechoor et al., 2009) .
While Ngn3 has been recognized as a 'master regulator' of endocrine cell formation (Rukstalis and Habener, 2009) , its expression per se is not sufficient for endocrine fate specification, rather the right dosage of Ngn3 is critical to secure the endocrine fate (Wang et al., 2010) . Lineage tracing of Ngn3-expressing WT cells have been shown to give rise to few acinar and ductal cells in addition to the predominantly endocrine lineage contribution (Gu et al., 2002; Schonhoff et al., 2004) . Recent lineage tracing of hypomorphic Ngn3 cells suggest that these non-endocrine Ngn3-expressing descendants may be the result of cells that failed to achieve the required threshold of Ngn3 for the endocrine fate, as Ngn3 heterozygous, or Ngn3-deficient, cells have an increased propensity to adopt acinar and ductal fates (Wang et al., 2010; Beucher et al., 2011) .
Furthermore, while the endocrine inducing properties of Ngn3 makes it a promising molecular factor for the creation of insulin producing cells, ectopic expression of Ngn3 in the mouse pancreas and in chick endoderm has been shown to cause a predominant increased glucagon cell formation but not the other endocrine cell types (Schwitzgebel et al., 2000; Apelqvist et al., 1999; Grapin-Botton et al., 2001 ). This appears to be rooted in a change in competence of Ngn3 þ cells in a time-dependent manner. Utilizing a tamoxifen-controlled Ngn3 gain-of-function approach competence for the beta cell fate was only observed at, and beyond the E12.5 time point, thus coinciding with the onset of the secondary transition (Johansson et al., 2007) .
As a means to investigate the ability of Ngn3 to promote pancreatic insulin-type cells, and address the molecular mechanisms that may explain the change in competence of the Ngn3-expressing cells, we created a conditional model of Ngn3 overexpression using a tetracycline transactivator-regulatory system. Utilizing the Pdx1-tTA TetOFF driver, we find that in absence of doxycycline, this transgenic model system is sufficiently powerful to induce a widespread endocrine cell conversion within the distal foregut segment effectively depleting the pancreatic/anterior duodenal segment progenitors. Bypassing this early effect through gestational timed intra-peritoneal doxycycline administrations we here describe the phenotypes of delayed activation of Ngn3 in pancreas. Unexpectedly, we found that conditionally activating Ngn3 prior to the secondary transition does not lead to increased beta cell formation, but the induction of pancreatic ductal cells with interspersed, glucagon-producing endocrine cells.
Mechanistically, we show that this experimental outcome resulted from a Ngn3-mediated change in the patterning of multipotent pancreatic progenitor cells (MPCs). Ectopic activation of Ngn3 leads to activation of Dll1, thus leading to cell extrinsic activation of Notch within the MPC population. These data are consistent with recent observations clarifying a role of Notch during tip/trunk patterning of the MPC population (Afelik et al., 2012; Cras-Meneur et al., 2009; Horn et al., 2012; Schaffer et al., 2010; Shih et al., 2012) , where Notch signaling is needed for TrPC (Trunk-Progenitor Cell) formation directly via Nkx6.1 activation (Afelik et al., 2012) . Our findings reveal that the previously observed gestational change in competence of Ngn3-expressing cells is a result of the pancreas undergoing TipPC/TrPC patterning as a prelude to the secondary transition and that Notch signaling establishes competence for the beta cell fate. Importantly, our data also uncovers a novel involvement of Notch signaling in the control of Ngn3 protein dynamics. We demonstrate the Notch, via Hes1, controls the stability of Ngn3 protein. This additional posttranslational control of Ngn3 decay helps explain the observed preservation of a mutually exclusive Hes1/Ngn3 expression pattern in both the Tet-regulated transgenic model as well as in the WT pancreas. These findings provides a conceptual platform in which rapid-change dynamics of an oscillating bHLH pair consisting of Ngn3 and Hes1 is linked to the possible simultaneous allocation of endocrine and ductal fates from a more homogenous Notch-active TrPC population.
Materials and methods

Animals
A linearized fragment containing pTRE2-Ngn3FLAG was used for oocyte injection, and founder lines were established. Functional testing was performed by intercrossing to the Pdx1-tTA transgenic knock-in line, allowing identification of four lines all of which provided similar phenotypes.
Embryonic studies and conditional gene activation
Gestational day 0.5 (E0.5) was defined as the day of vaginal plug detection. To temporarily allow for suppression of transgenic (TG) expression, doxycycline (Dox) was administered (0.05 mg/g body weight) as once-daily intraperitoneal (i.p.) injections at times noted. Throughout, control littermates either of WT, or single transgenic (STG) for the pTRE2-Ngn3 genotype were used for comparative analysis. In all studies, these developed like WT embryos. Embryonic genotypes were defined by PCR on limb/paw tissue.
Histology, immunohistochemistry and microscopy
Mouse tissue: for each analysis, at least n¼3 double transgenic (DTG) type pancreatic, or dissected distal foregut/midgut regions were compared to at least 3 littermate controls (for specific numbers, see supp. Table S1 ). Endodermal tissues were fixed in 4% paraformaldehyde (PFA) at 4 1C for 12-24 h. PFA-fixed specimens were equilibrated in 30% sucrose in PBS at 4 1C overnight, transferred to a 1:1 mixture of 30% sucrose in PBS:OCT for 4 h, hereafter transferred to OCT overnight and subsequently embedded in OCT by slow freezing. For immunofluorescence staining, sections were dried at 37 1C and microwave treated followed by washing and blocking. Primary antibodies were applied overnight at 4 1C. Next day, secondary antibodies were applied for 1 h at room temperature. Following washing, slides were mounted.
Pancreatic explants and DAPT treatment
The dorsal pancreatic rudiment of E12.5 mouse embryos was removed in cold PBS and transferred to a tissue culture filter insert system. Pancreatic explants were treated with N-(S)-phenyl-glycine-t-butyl ester (DAPT) (Sigma) in DMSO diluted in medium to final concentrations of 5-100 mM. Cultures were incubated at 37 1C for 4 days and medium was changed daily.
Morphometry and cell counting
Quantitative morphometry of various cell types were performed as described (Kobberup et al., 2010) . The relative cellular area was measured using ImagePro Software (Media Cybernetics, Bethesda, MD). Student's t-test (two-tailed) was used to determine statistical significance and significance was regarded as p r0.05.
Quantitative real time RT-PCR (qRT-PCR)
Total RNA was isolated from dissected pancreas, treated with DNase and reverse-transcribed using Superscript II (Invitrogen). Quantitative real time PCR was performed using an ABI 7500 Real Time PCR System. Primer sequences are available upon request. The relative concentration of RNA for each gene to GAPDH was determined using the DDCT method.
Results
Ectopic Ngn3 expression leads to accelerated endocrine differentiation at the expense of pancreatic progenitors
To explore the possibility of enhancing the induction of pancreatic b cell fate over other fates such as a cells through temporal control of Ngn3 overexpression, we created a doxycycline inducible Ngn3 transgenic mouse, pTRE2-Ngn3. These mice were generated by pro-nuclear injections with a linearized pTRE2-Ngn3 DNA construct. Following transgenic founder screening using a RIP-rtTA TetON driver line and Doxycycline (Dox) provision (supp. Fig. S1A-F) , we used a TetOFF Pdx1-tTA knock-in line (Pdx1-tTA KI , (Holland et al., 2002) and supp. Fig. S1G-I ) to evaluate the effect of ectopic Ngn3 expression within the Pdx1 domain in the developing foregut. In control experiments with continuous Dox administration to pregnant females, Pdx1-tTA KI ;pTRE2-Ngn3 crosses revealed complete inactivity of the transgene at all ages studied (data not shown). Ectopic Ngn3 gene induction was achieved by omitting Dox in the drinking water (Fig. 1A) . Double-transgenic Pdx1-tTA KI ;pTRE2-Ngn3 embryos (Ngn3 ON) harvested at gestational day 18.5 (E18.5) displayed significant pancreatic hypoplasia as previously reported for ectopic Ngn3 expression in the Pdx1 domain (Fig. 1C , (Apelqvist et al., 1999) ), with the exception that we observed a more pronounced hypoplasia of the pancreas, as well as a loss of gut continuity at the antral stomach/duodenal level (Fig. 1C) . In this study, we focus on the effect of Ngn3 overexpression on the developing pancreas; the effects within the lateral duodenal wall and developing stomach will be described elsewhere. The Ngn3-mediated pancreatic organ hypoplasia could conceivably be due to progenitor depletion through accelerated differentiation. To verify this we analyzed the pancreas at E11.5 and observed that the remnant pancreatic tissue in Ngn3 ON pancreas consisted predominantly of glucagon-positive (Glu þ) cells, most of which expressed Pdx1 at low to intermediate levels ( Fig. 1E ). Such cells were not proliferative as judged by absence of M-phase activity (pHH3 staining, Fig. 1E ). The WT pancreas displayed ubiquitous Pdx1 expression and cells were proliferating (Fig. 1D ). Ngn3 expression was detected in the DTG pancreas, throughout the central clustering of glucagon-expressing endocrine cells (compare Fig. 1E-G) . Almost absolute progenitor depletion was observed. A complete loss of the progenitor and later acinar marker CPA1 was prominent (Fig. 1I ) and Sox9 expression was essentially abrogated (Fig. 1K) . We also found no evidence of Muc1 expression (Fig. 1I ). Mucin1 expression reveals the initial emergence of tubulogenesis through microlumen formation and signifying epithelial apical polarity (Fig. 1H , and (Kesavan et al., 2009) ). In agreement, Dolichos Biflorus agglutinin (DBA), a more mature marker of pancreatic ductal cells, was not expressed in either WT or DTG pancreas, in agreement with the fact that terminal ductal cell differentiation had not commenced at E11.5 ( Fig. 1J and K) . The progenitor marker Nkx6.1 remained expressed at high levels, throughout the DTG pancreas (Fig. 1M) . In WT, Nkx6.1 is at this stage becoming restricted to centrally-located progenitor cells, and gradually diminishing in expression in outer-layer epithelial cells (Fig. 1L) . Thus far the phenotype observed here corroborates previous published reports indicating that when expressed ectopically in the pancreatic endoderm, at the onset of pancreas development, Ngn3 induces primarily a Gluþ endocrine fate. As indicated by Johansson et al., this is because the early pancreatic endoderm is competent for glucagonþ fate induction, and only becomes competent to differentiate into insulinþ cells at E11.5 (Johansson et al., 2007) . To circumvent this and to facilitate the formation of insulinþ cells, we used Dox to bypass the initial Ngn3-induced effects observed in the Ngn3 ON model. We administered Dox through intraperitoneal (i.p.) injections into the pregnant mouse at gestational day 7.5 (E7.5) and E9.5, and isolated embryos at E10.5, E11.5 and E12.5 ( Fig. 2A and B) . The kinetics of Ngn3 induction was assessed by qRT-PCR at E10.5 and E11.5. We did not observe an increase in total Ngn3 mRNA at 24 h post-Dox administration (E10.5), but at 48 h (E11.5), total levels of Ngn3 mRNA was 6.8-fold increased, compared to WT (Fig. 2B ). These Pdx1-tTA KI ;pTRE2-Ngn3 DTG embryos receiving Dox at E7.5 and E9.5 are in the following referred to as Ngn3 Delayed ON embryos. The histology of E12.5 Ngn3 Delayed ON pancreas resembled that of WT pancreas, displaying uniform Pdx1 and Sox9 expression ( Fig. 2D-F) . Epithelial cells were proliferative in both WT and Ngn3 Delayed ON pancreas as assessed by BrdU incorporation (data not shown). The excessive formation of Gluþ clusters causing progenitor depletion observed in Ngn3 ON embryos was not prevalent (Fig. 2D ). All Ngn3 Delayed ON embryos, at all stages analyzed successfully bypassed the apancreatic phenotype of the Ngn3 ON condition (example shown in Fig. 3C ).
Overexpression of Ngn3 prior to the secondary transition results in the induction of pancreatic duct cells
With the right Doxycyline administration required to achieve Ngn3 overexpression at E11.5 established we were interested in the differentiation abilities of Ngn3 Delayed ON pancreas. Were such able to exclusively generate endocrine cells that were predominantly insulinþ as previously reported by Johansson et al. Johansson et al. (2007) . To address this, we analyzed E14.5 Ngn3 Delayed ON pancreas ( Fig. 3A and C) . At E14.5, Ngn3 Delayed ON embryos developed significant pancreatic tissue, of both dorsal and ventral origin (Fig. 3C) . Surprisingly, histological analysis revealed an expanded tubular network of b-catenin-expressing cells, interspersed with few cells expressing Nkx6.1 (Fig. 3E ). There was a noticeable lack of epithelial branching and a general absence of forming acini at epithelial tips ( Fig. 3D and E). The reduction of Nkx6.1 indicated that the epithelial cells were not of a progenitor type. This was confirmed by using markers of terminally differentiated cells, as the epithelialderived pancreatic tissue of Ngn3 Delayed ON (E14.5) consisted mainly of two types of cells: glucagon expressing endocrine cells ( Fig. 3I and M) and DBA-expressing ductal cells (Fig. 3G ). The dramatic increase in relative cell areas of Gluþ and DBAþ cells were offset by reductions in acinar and insulinþ cells (Fig. 3I, M and N) , and agreed with the general absence of Nkx.6.1 expression. Acinar cells (amylaseþ) were largely absent ( Fig. 3I and N ), but present in WT (Fig. 3H) ; and insulinþ cells were similarly almost completely absent ( Fig. 3M and N) but present in WT ( Fig. 3L and N) .
The 17-fold increase in ductal cell differentiation ( Fig. 3N ) was surprising, and the DBAþ cell population outnumbered that of the endocrine cells ( Fig. 3G and I ). To further clarify the phenotypic state of the ductal cells induced by Ngn3, we analyzed the expression of Hnf1b, encoded by Tcf2. Hnf1b initially overlaps with Nkx6.1 and Pdx1 within pancreatic progenitors (Maestro et al., 2003) but only ductal cells continue to express Hnf1b following differentiation. In Ngn3 Delayed ON E14.5 pancreas, we observed that the cuboidal-epithelial DBAþ expressing cells were Hnf1b þ, and ciliated as noted by presence of ciliary basal bodies positive for acetylated tubulin (data not shown). This cellular phenotype is identical to that of normal pancreatic ductal cells. These ductal cells did not express Ngn3 (Fig. 3K ).
Ectopic Ngn3 expression leads to lateral induction of Notch signaling
The degree of ductal cell differentiation was both unexpected and undesired. To elucidate the molecular underpinnings of this phenotype, we carried out a detailed analysis of the Ngn3 Delayed ON pancreas at E12.5. We employed qRT-PCR to screen a panel of molecular markers for differences between the Delayed ON pancreas and WT. On average total Ngn3 mRNA was increased 9.1-fold over WT. Attesting to the functional ability of ectopic Ngn3 protein, we noted a significant activation of Ngn3 target genes, including NeuroD1, Pax4, Pax6 and Arx (Fig. 4A) . Only a modest ( $ 1.2-fold) increase in glucagon (Gcg) mRNA expression was detected, but insulin (Ins) was not expressed at significant levels in WT, or DTG pancreas at this stage. Despite the increase in total Ngn3 level, we were surprised to find that endogenous Ngn3 expression was attenuated to $ 20% of WT levels. A possible explanation for the reduced expression of endogenous Ngn3 could be increased activity of Notch signaling. We addressed expression of the Dll1 gene, which has been identified as a target of Ngn3 (Treff et al., 2006; Gasa et al., 2004) . Dll1 expression was significantly increased (2.4-fold compared to WT) (Fig. 4A) . A similar increase was noted in the Notch target gene Hes1, which is critical for pancreatic development (Jensen et al., 2000) , whereas expression of multiple other hairy/enhancer-of-split family members were unchanged (data not shown).
The observed increased expression of the Notch ligand Dll1, and the Notch target Hes1, argued for general elevation of Notch signaling. To investigate the cellular subset able to promote Notch signaling in the pancreas, as well as the recipient population, we performed Ngn3/Dll1 co-expression analysis. Intensity of membrane-associated Dll1 protein was strongly elevated in E12.5 (Fig. 4C) pancreas, compared to WT (Fig. 4B) . Qualitatively, the expression of Dll1 in the basal-membrane was similar between WT and DTG pancreas. Dll1 was expressed by Ngn3-expressing cells, however, it was also detectable in Ngn3-negative cells, adjacent to Ngn3-positive cells. Considering that the total number of Ngn3-expressing cells only represented a subset of epithelial cells these data argue that cell-extrinsic activation of Notch signaling is a consequence of the experimental elevation of Ngn3, and that Dll1 is a plausible mediator.
Ngn3 is capable of promoting the pancreatic trunk field prior to onset of terminal ductal and endocrine differentiation
The increased expression of the Notch component genes Dll1 and Hes1 was paralleled by a commensurate decrease in pro-acinar (tip) markers. Expression of the Ptf1a gene was reduced to $50% of WT levels, coupled with a more drastic reduction in Cpa1 expression level (Fig. 4A ). This was contrasted by a sustained expression of the, at this time, epithelial progenitor markers Krt19, and Hnf1b genes. But the expression of Sox9 was reduced by $ 40%, suggesting a general loss of Sox9 mRNA, as the protein expression remained qualitatively intact (Fig. 2F) . Although we did not find evidence of increased terminal ductal differentiation at this stage, a significant increase in expression of the Onecut-family member 2 (Oc2) was evident (Fig. 4A) . Interestingly, expression of the homologous gene Oc1 (encoding Hnf6, a known regulator of Ngn3 expression), was significantly reduced to $20% of WT levels (Fig. 4A) .
We and others recently reported the requirement of Notch for patterning of MPCs towards pro-endocrine/duct (trunk) fate (Afelik et al., 2012; Horn et al., 2012) . The increased level of Notch coupled with the reduction of pro-acinar markers in our qRT-PCR analysis therefore prompted us to examine the tip-trunk pattern in the Ngn3 Delayed ON pancreas with histology. We addressed the creation of the pro-acinar field. Ptf1a is a useful marker, at E12.5 being confined to distal tip cells contacting the outer basal lamina of the epithelium (Fig. 4D ). The nuclear staining for Ptf1a was almost abolished in Ngn3 Delayed ON pancreas (Fig. 4E) . This loss was proportionate with a reduction in staining for CPA1 (Fig. 4C) , as well as amylase (not shown).
Next, we addressed the creation of the trunk progenitor field. Nkx6.1 is a useful marker, as this becomes localized to the trunk field prior to E12.5 and is excluded from the distal tip field ( Fig. 4F and (Jorgensen et al., 2007) ). Nkx6.1 has been shown to operate antagonistically to Ptf1a (Schaffer et al., 2010) . Nkx6.1 was widely distributed throughout the E12.5 Ngn3 Delayed ON pancreas (Fig. 4G) ; expressed in cells analogous to a tip-position, at the epithelial/mesenchymal border. Morphometrical analysis confirmed the relative shift between the Nkx6.1 and Ptf1a trunk/tip markers (Fig. 4H) . We conclude that ectopic Ngn3 expression elicited a shift towards Nkx6.1 expression, with a concomitant loss of Ptf1a expression, and hereby distorts the TrPC/TipPC pattern that normally segregates multipotent pancreatic progenitors prior to the secondary transition (Schaffer et al., 2010; Zhou et al., 2007) .
We were interested in the differentiation status of the Ngn3-expressing cells in the Delayed ON condition. In this model, Ngn3 expression would almost exclusively be transgene-driven, as the endogenous Ngn3 gene was effectively suppressed (Fig. 4A) . Do such cells represent Ngn3 þ expressing progenitors, or alternatively partially differentiated, yet lineage-committed endocrine cells? To evaluate this, we performed co-expression analysis of Pax6 and Ngn3 (supp. Fig. S2 ). Pax6 is an early, endocrine-specific marker associated with post-mitotic endocrine cells irrespective of sub-type, and is therefore a lineage commitment marker. Ngn3þ cells in the Delayed ON pancreas, irrespective of age analyzed (E11.5, E12,5, and E14,5) were not co-expressing Pax6, except for very rare cells (example shown in supp. Fig. S2D ). Clustered Pax6þ/Ngn3 À cells were present in both WT, and Delayed ON DTG pancreas, showing that in both situations; endocrine cell formation is associated with a loss of Ngn3 in the post-mitotic endocrine descendant. Because the endocrine complement of the Ngn3 Delayed ON pancreas lacks Pdx1-expressing beta-cells (Fig. 3M) , this also explains the lack of Pax6/Ngn3 double-positive cells in the DTG pancreas.
Differential ability of Ngn3 in the induction of endocrine versus ductal fate
The Ngn3 Delayed ON phenotype when analyzed at E14.5 and E12.5 differed substantially. When analyzed at E12.5 we detected significant levels of Ngn3 expression, yet at E14.5, Ngn3 protein was substantially reduced. Because the cell complement observed at E14.5 consisted of differentiated cells, whereas at E12.5, we found that most cells were of a pancreatic progenitor type, patterned towards the TrPC type, these data argued that TrPC's had executed a terminal fate selection in the period of E12.5-E14.5. We were interested if this event required ongoing transgenic Ngn3 expression. To clarify, we administered Dox to Pdx1-tTA KI ;pTRE2-Ngn3 pregnant females at E7.5, E9.5 as well as at E12.5, followed by analysis at E14.5 (supp. Fig. S3A ). The timewindow for transgenic Ngn3 expression would thus be limited to a brief period between E11.5 and E12.5. These embryos are referred to as Ngn3 Brief ON, (supp. Fig. S3B K) . In this experiment, the formation of pancreatic endocrine cells was not prevalent, yet we noted a reduction in acinar cell formation (CPA1þ, Ptf1aþ, supp. Fig. S3C , E and L), as well as increased ductal formation (DBAþ , Hnf1b þ (supp. Fig. S3C , G, I and L)), although not as prominent as observed in the E14.5 Delayed ON embryos. Glu þ cells were only modestly increased in density (1.4-fold) (supp. Fig. 3K and L), compared to the approximate 35-fold induction observed in the Ngn3 Delayed ON E14.5 pancreas (Fig. 3N) . Also, only rare insulin þ cells were detected (Supp. Fig. S3G and L). Expanded trunk regions expressing Pdx1 was found (supp. Fig. S3I and K). Ngn3-expressing cells were identified in the trunk regions (supp. Fig. S3G) , and given the experimental administration of Doxycycline post-E12.5 in the Brief ON experiment, these cells are presumably expressing the endogenous Ngn3 protein, in accordance with the trunk being competent for Ngn3 activation. Agreeing with the Ngn3 delayed ON model ductal induction was found to be disproportionately higher than the induction of Glu þ cells under these conditions as based on morphometrical assessment (supp. Fig. S3L ). This experiment demonstrates not only that continuous expression of Ngn3 is needed for complete TrPC patterning of the MPC pool, as suggested previously (Wang et al., 2009 ), but also that a brief exposure of Ngn3 expression is less effective in the induction of endocrine fate, as compared to its ability to induce of ductal cells. Indirectly, this experimental outcome is in agreement with a threshold mechanism of Ngn3 in the induction of endocrine fate, as also suggested previously (Wang et al., 2010) .
Preservation of the dynamics of Hes1/Ngn3 expression, and consequently lateral inhibition, during ectopic Ngn3 expression
In the developing pancreas, the expression of Ngn3 and Hes1 are mutually exclusive and the outcome of previous targeted deletion of Notch component genes such as Hes1, Dll1 and Rbpsuh suggest that Ngn3 cells are engaged in lateral inhibition with Notchactive (Hes1þ) cells (Apelqvist et al., 1999; Jensen et al., 2000) . We therefore wondered if the induction of Hes1 through Ngn3 overexpression would result in Ngn3þ/Hes1þ double-positive cells, as the driving promoter (Pdx1) for the transgenic system should be refractory to lateral inhibition and could such cells account for the unexpected ductal phenotype? To do this, we carried out co-immunostaining of Ngn3 and the oscillatory Notch-target Hes1 (Hirata et al., 2002) and also related the expression of Hes1 to the progenitor marker Sox9. In WT pancreas, Hes1 protein is expressed heterogeneously but widely throughout the progenitor pool at E11.5 (Fig. 5A ). This expression always overlaps with Sox9 (Fig. 5A) , although Sox9 is more homogenously expressed, in agreement with Sox9 being upstream of Hes1 (Seymour et al., 2007) . This pattern exists prior to the emergence of Ngn3þ cells in WT pancreas between E11.5-E13.5 (Fig. 5A-C) . Consequently, Hes1 is expressed dynamically in individual progenitor cells prior to Ngn34Dll14 Notch lateral signaling, and implies that Notch signaling is engaged prior to normal onset of Ngn3 expression at the secondary transition at E13.5. In WT, the numbers of Ngn3þ cells gradually increase over E11.5-E13.5 (Fig. 5E G) , decreasing thereafter (not shown). At these time points, Ngn3 is always reciprocally expressed with Hes1, in agreement with the mechanism of lateral inhibition. At E13.5, Hes1-negative/Ngn3-negative cells are found, likely corresponding to differentiated cells (Fig. 5G, yellow arrows) . Analyzing Ngn3 Delayed ON pancreas at E11.5, the Sox9/Hes1 expression pattern remained qualitatively intact compared to WT (Fig. 5D ). Yet, the number of Ngn3þ cells (which are mainly derived from TG production, as endogenous Ngn3 mRNA is effectively reduced, Fig. 4A ) was markedly increased at E11.5 as compared to WT pancreas as expected. Surprisingly, Ngn3 and Hes1 remained reciprocally expressed (Fig. 5H) , qualitatively similar to WT at E13.5 (Fig. 5G) .
Notch signaling controls Ngn3 protein stability
While Hes1 is known to directly inhibit Ngn3 expression transcriptionally (Lee et al., 2001) , this would be an insufficient explanation for the observed results in which Ngn3 was driven by a Pdx1-tTA;tetO governed system. Therefore, the lack of homogenous Ngn3 protein expression in the DTG pancreas strongly suggested that Notch-mediated lateral signaling negatively controls Ngn3 protein. As destabilization of other bHLH factors, including NGN, and hASH1 has been observed (Vosper et al., 2007) which have also implicated Notch (Sriuranpong et al., 2002) , we then tested if a similar mechanism might operate in the pancreas. As a means to mechanistically address this question, were cultured for 4 days in the absence/presence of 100 mM DAPT. Sections were stained against Mucin1, carboxypeptidase1 (CPA) and glucagon (Glu). (C) qRT-PCR analysis of explants performed as in (A) and (B). Pancreatic marker genes were assessed and fold-changes to WT explants treated with DMSO were calculated by the DD ct method, using GAPDH mRNA as internal standard. (D-K) Ngn3 Delayed ON pancreas (E12.5, doxycycline was provided at E7.5, E9.5 as in Fig. 2A ) was isolated and subjected to 4 days of explant culture with and without DAPT as described in (A) we first determined the half-life of Ngn3 protein. Using three different heterologous cell lines (HepG2, Hek293, and CHO) conditionally expressing Ngn3, we observed a rapid decay of Ngn3 protein when further protein synthesis is blocked by addition of cycloheximide (CHX); control protein, beta-Actin, remained stable under these conditions (Fig. 5I and data not shown) . As the Notch signaling pathway is involved in growth control of HepG2 cells, and because these cells express Delta1, Jagged1, Notch3 ICD, and Hes1 (Suwanjunee et al., 2008) , we chose the HepG2 cell line for more detailed studies. Through time course experiments after addition of CHX, we defined the half-life of Ngn3 to be very short (T 1/2 $ 30 0 ) (Fig. 5I) , comparable to T 1/2 values for Ngn1, and Mash1, as shown by others. Exposure of Ngn3 expressing HepG2 cells to the proteasomal inhibitor MG132 stabilized the protein, T 1/2 43h (Fig. 5I) , suggesting that Ngn3 half-life is regulated by proteasomal activity. We then tested if Notch signaling played a role in Ngn3 protein accumulation and Ngn3 degradation in HepG2 cells by co-expression of the Notch1, or Notch2 intracellular domains (N1ICD, N2ICD, Fig. 5J and L) . In the presence of Notch ICDs, Ngn3 protein failed to accumulate (Fig. 5J) , and the measured T 1/2 of Ngn3 was extremely short (T 1/2 o15 0 , Fig. 5L ). Investigating if transcriptional regulation was required downstream of Notch processing, we co-transfected a dominant negative version of the prerequisite Notch signaling co-activator Mastermind-like-1 (DN-MAML1). This completely abrogated the ability of Notch in destabilizing Ngn3, and furthermore led to a marked increase in total amounts of Ngn3 produced in the HepG2 cells ( Fig. 5J and L) . We conclude that the basal turnover of Ngn3 in the HepG2 line was mainly conferred by the ongoing Notch signaling in those cells; a finding confirmed by an increase in total Ngn3 protein levels-with a commensurate protein stabilizing effect in the presence of the Notch inhibitor, N-[N-(3,5-difluorophenacetyl)-1-alanyl]-S-phenylglycine t-butyl ester (DAPT) at 50 mM (Fig. 5L, and data not shown). It could be argued that the mechanistic insight derived from the HepG2 studies was cell culture specific, but E14.5 mouse pancreatic explant studies (WT) using CHX and DAPT revealed that endogenous Ngn3 protein was indeed rapidly turning over due to proteasomal degradation, as this loss was abrogated by exposure to MG132 (Fig. 5K) . Interestingly, exposure of explants to DAPT led to similar levels of Ngn3 protein stability as in pancreatic explants treated with the proteasomal inhibitor MG132 over the same time course (Fig. 5K) . Given that the Ngn3 protein stability conferred by DAPT alone is comparable to that of MG132 treated pancreas, we conclude that Notch signaling is the predominant regulator of Ngn3 protein stability in the E14.5 normal mouse pancreas, possibly priming Ngn3 for subsequent proteasomal degradation.
While the mechanism linking Notch signaling to Ngn3 degradation is unknown, one possibility could be through Notch mediated induction of Skp2 expression. Skp2 encodes an E3-ubiquitin protein ligase that has been shown to be activated by Notch. However, overexpression of Skp2 protein did not affect Ngn3 turnover. In contrast, overexpression of Hes1 protein led to destabilization of Ngn3, with almost identical kinetics as observed with N1ICD, or N2ICD (Fig. 5L) . Deletion of the C-terminal domain of Hes1 abrogated this effect (Fig. 5L) . To ascertain if Hes1 was able to control Ngn3 turnover in absence of transcriptional events downstream of active Notch, we over-expressed DN-MAML1 in the presence of Hes1. While DN-MAML1 led to a marked increase in total Ngn3 protein as expected, Hes1 remained able to destabilize Ngn3 (Fig. 5L) . Consequently, Hes1 is-independent of other transcriptional events elicited by Notch-able to control Ngn3 degradation.
Induction of Notch signaling is the underlying molecular mechanism for Ngn3-mediated ductal cell differentiation Our previous data did not allow us to formally discriminate which molecular mechanism(s) account for the induction of ductal cells by Ngn3. Given that pancreatic ductal cells form in Ngn3 null mice (Gradwohl et al., 2000) , and because ductal genes have not been identified as direct Ngn3 targets, we set forth to determine if a cell-extrinsic mechanism involving Notch indeed was causal for the duct cell induction observed in Ngn3 Delayed ON pancreas. We first tested if pancreatic ductal cell differentiation was dependent on Notch. We cultured WT pancreatic explants in the presence of DAPT (Fig. 6A-C) . These experiments were based on E12.5 pancreas, as at that age, the majority of tip/trunk patterning has occurred, and cells are actively undergoing terminal fate decisions. These cultures developed significant numbers of Muc1þ ductal cells during culture in absence of DAPT (Fig. 6A) , with a density exceeding that found invivo. Acinar cell development (CPA1þ) proceeded in WT (Fig. 6A ), albeit at a much reduced level compared to normal development. In the presence of 25-50 mM DAPT, ductal cell development was significantly reduced, and fully abolished at 100 mM DAPT addition (data not shown, and Fig. 6B ). Given that Notch processing inhibition strongly affected cellular differentiation, we investigated this further by performing qRT-PCR on similar-type explants (Fig. 6C) . As shown by others, Notch signaling inhibition led to quite dramatic increases in endocrine cell differentiation (dose-dependent increases observed for Ngn3, NeuroD1), and it also strongly promoted acinar gene expression (Cpa1, Cpa2, Ptf1a). However, variable effects on endocrine subtypes was noted, where at high levels of DAPT (100 mM),
Gcg expression was reduced, while Ins1, Ins2 was further enhanced. In agreement with the increased levels of Ins1and Ins2, Nkx6.1 was also elevated, here reflecting the association of Nkx6.1 with the mature beta cell, rather than the TrPC. This notion is supported by a commensurate reduction of other TrPC marker genes, such as Sox9 and Hnf1b (Tcf21) The loss of Oc2indicate loss of ductal fate, in agreement with the observed reduction of Muc1þ ductal cells (Fig. 6B) .
Given that Dll1 and Hes1 were 42-fold increased in the E12.5 Ngn3 Delayed ON pancreas, we next asked to what degree Notch processing was also required for the enhanced Ngn3-mediated ductal cell formation in that model. Similar to above, microdissected E12.5 Ngn3 Delayed ON pancreas was cultured for 4 days ex-vivo with and without DAPT (Fig. 6D-K) . In contrast to WT explants, Ngn3 Delayed ON pancreas developed in a quite similar manner as observed in-vivo; in addition to widespread ductal formation, glucagon-producing clusters were observed, and extremely few acinar cells were found (Fig. 6D, F and H) . Similar results were obtained using staining for Hnf1b (data not shown). As observed for WT pancreas, acinar density (CPA1þ cells) was much increased upon DAPT treatment ( Fig. 6E and G) . The Ngn3-mediated ductal cell formation was abrogated by DAPT treatment (Fig. 6E, G and I) . Of note, numerous Pdx1 þ/Insþ endocrine cells were observed upon DAPT treatment (Fig. 6K) , while glucagon-expressing cells (normally encountered at significant numbers in non-DAPT treated Ngn3 Delayed ON pancreas, Fig. 6D , H and J) were correspondingly reduced (Fig. 6E, I and K). We conclude that Notch signaling is required for both normal, as well as Ngn3-mediated, pancreatic ductal cell development, and that blocking this pathway promotes acinar and endocrine fates at the expense of ductal cells. Of note, at high levels of DAPT treatment, g-secretase inhibition impacts endocrine subtype determination as well, and if a concomitant increase in Ngn3 protein is provided, the organ regains capacity for significant insulin-cell differentiation.
Discussion
We have here elucidated an ability of Ngn3 in promoting pancreatic ductal cell formation based on the capacity of Ngn3 in creating a bipotential trunk field via Notch signaling. Loss-of function studies of Ngn3 has revealed a critical requirement for the gene in the development of all pancreatic endocrine cells (Gradwohl et al., 2000) and the current perspective of Ngn3 function pivots around this role in the early endocrine lineage determination. Our data is in agreement with a mechanism by which Ngn3 is capable of inducing endocrine cell formation provided it exceeds a repressive threshold for differentiation set by Notch/Hes1 signaling. Ngn3 expression is able to exert dramatic changes to organ development when expressed prior to its normal induction window resulting in endocrine terminal fates at the secondary transition. We confirm that elevated Ngn3 expression activates endocrine progenitor genes (Arx, Pax4, NeuroD) prior to terminal differentiation, and this support a cell-intrinsic effect of Ngn3 on endocrine differentiation. Yet, this simple linear/ causal relationship between Ngn3 activity and the endocrine fate fails to capture important dynamics of Ngn3 upon the Notch signaling system. This also inadequately describes the dynamics of Ngn3 protein stability as controlled via Notch/Hes1. Our data demonstrate that overexpression of Ngn3 can elevate Notch/Hes1 signaling, which in turn not only affects the compartmentalization of the progenitor domain as an initial event, but subsequently negatively influences the endocrine differentiation process in the majority of such endocrine/ductal progenitors. This mechanism explains the rapid dynamic changes in expression of opposing bHLH factors (Ngn3, Hes1) that either suppress (Hes1) or promote (Ngn3) cell differentiation. Understanding that the foundation of this bilateral system rests on control of Ngn3 protein stability is clearly relevant while seeking to optimize endocrine cell induction. Our data using pancreatic explants provides a first line of evidence that the largely undesired lateral ductal fate induction occurring due to Ngn3 expression can be successfully circumvented by modulation of Notch signaling.
Ngn3 impacts Notch signaling and affects pancreatic progenitor trunk-field patterning
Our findings reveal that conditional activation of a proendocrine drive leads to very different outcomes dependent on gestational time. If this occurs at time of budding, multipotent progenitor cells (MPCs) will adopt a glucagon-expressing fate, and MPC depletion ensues, with an almost apancreatic phenotype as a result. Conditional activation of Ngn3 at a later stage, as in the Ngn3 Delayed ON model, leads to suppression of acinar fate, but MPCs are capable of adopting both endocrine and duct fates. While we were initially surprised in finding that the predominant terminally differentiated cell type was a ductal, rather than an endocrine one, upon delayed Ngn3 expression, this outcome is in agreement with more recent investigations into the spatial and temporal role of Notch in pancreas. Our data suggest that increased Ngn3-expression leads to Dll1 expression, and thus activation of Notch hereby impacting TrPC formation. Thus, the phenotype of Ngn3 gain-of-function is a composite of cell intrinsic (endocrine differentiation) and cell-extrinsic events (via Notch activation leading to a MPC4TrPC patterning change). When Ngn3 expression is elevated prior to induction of terminally differentiated endocrine cells, Ptf1a þ cells are lost, whereas Nkx6.1þ cells expand. The Ptf1a/Nkx6.1 pair is antagonistic to each other and the relative expression of the two factors determine tip/trunk field establishment in multipotent progenitors (Schaffer et al., 2010) .
The more recent role of Notch in progenitor patterning begs mechanistic comparisons to the previously described role of Notch in lateral inhibition. Lateral inhibition involves the reciprocal signaling between adjacent multipotent progenitors governing the eventual endocrine fate outcome. This mechanism has been considered relying on transcriptional repression but this is an incomplete explanation considering the impact of Notch on Ngn3 protein half-life as described here. Notwithstanding, lateral inhibition also fails to provide an adequate picture of the role of Notch as this pathway impacts the segregation of multipotent progenitor cells into tip/trunk positional fields prior to their terminal fate allocation; a process originally described by Zhou et al. Zhou et al. (2007) . While the possible patterning role of Notch was initially discovered during studies of Presenilin (Ps1/ Ps2) mutants, where a surprising fate switch of Ngn3-expressing cells into the acinar lineage was observed (Cras-Meneur et al., 2009 ), more recent data provided direct evidence. Expression of NICD in Pdx1þ cells induced expression of the TrPC patterning marker Nkx6.1 (Schaffer et al., 2010) . Complementing this finding, we observed that pancreatic MPCs conditionally experiencing Notch signaling inhibition through expression of DN-MAML1 became competitively disadvantaged against WT cells in adopting a trunk-type identity at the time of compartmentalization (E11.5-E12.5), and we showed that the RBPjK factor was directly bound to the Nkx6.1 regulatory region (Afelik et al., 2012) . Further functional evidence for a role of Notch in MPC 4TrPC patterning was obtained from studies of Mindbomb and conditional Hes1 mutants, revealing a requirement of Notch signaling in the development of TrPC-descendant ductal and endocrine cells (Horn et al., 2012) , and this process appear to occur through a process of Sox9 maintenance from a Notch-active pool (Shih et al., 2012) . Together, these data suggest that prior to the secondary transition, and thus prior to normal Ngn3 activation, Notch signaling is ongoing and serves to pre-pattern MPC towards a bi-potential endocrine/ductal progenitor type.
Notch signaling and the gestational control of endocrine subtype determination
Our initial motivation for investigating Ngn3 through a novel conditional activation model was to gain insight into the molecular mechanisms that may help explain why the competence of the Ngn3-expressing populations changes so dramatically with gestational age (Johansson et al., 2007) . At early pancreatic development, Ngn3-expressors are competent for acinar fate, yet such competence is lost over time. The competence for beta-cell fate is not reached until E12.5, whereas earlier time points, most endocrine cells that develop in response to Ngn3 are of a glucagon-expressing type. Our data suggests that both these time-dependent changes in competence is a response to the degree of Notch signaling in the MPC pool. Because acinar competence depends on TipPC patterning, then, as the bipotential pro-endocrine/ductal TrPC forms between E11.5-E12.5 it is to be expected that Ngn3-expressing cells lose acinar competence as the pancreas reaches the E12.5 stage. Regarding the endocrine competence dynamics (beta-cell formation), a similar argument can be posited. Using explant studies, we observed the emergence of pancreatic beta cells from Ngn3 Delayed-ON pancreas, upon providing DAPT after the TrPC patterning effect of the transgene had been established. One possibility explaining endocrine gestational dependency is that beta-cell competence is related to TrPC formation and that this is at least partially explained through Notch activation of Nkx6.1. It is well known that Nkx6.1 is critical for beta cell function in the adult state and it is also involved in beta cell formation during embryonic stages. Relevant questions emerge such as how Nkx6.1 presence may impact the alpha/beta cell subtype switch that is controlled by relative Pax4/Arx expression? Also, could Notch/Hes1 be involved in controlling the Pax4/ Arx dynamics in a more direct manner? While our data does not specifically address the importance of duration of Notch signaling it is possible that Notch-mediated epigenetic changes, accumulating over time, could be involved development of beta cell competence, and that such would be propagated from TrPC determinant loci, including Nkx6.1. If so, the prolongation of Notch activation, rather than total level of induction, could be critical. Some of these emerging opportunities might influence the differentiation strategies of pluripotent cells towards the beta cell fate.
Notch-mediated control of bHLH complex formation via effects on protein stability
We uncovered a novel post-transcriptional involvement of Notch signaling negatively controlling Ngn3 protein. The current basis for understanding lateral inhibition in pancreas, as well as elsewhere, largely centers on cross-repressive transcriptional control. Transcriptional repressive systems are known in somitogenesis, as well as neurogenesis, and the current paradigm is that Notch-driven Hesclass protein production leading to repression of transcription of various lineage-specific bHLH genes, such as Ngn3 in pancreas (Lee et al., 2001 ). For instance, in the Ngn3 Delayed ON model, there is an almost complete abrogation of expression of endogenous Ngn3 mRNA, as would be expected through transcriptional repression of Ngn3 by Hes1 (Fig. 4H ). In addition, we now uncover that Notchcontrolled proteolysis of Ngn3 also occurs. Similar results have been described for Notch-induced ubiquitination and degradation of hASH1 (Sriuranpong et al., 2002) , E2A (Nie et al., 2003) , and TAL/ SCL (Nie et al., 2008) . These bHLH factors have demonstrated halflives o30 min and Ngn3 is in a similar range. Given that Hes1 is an unstable protein in all contexts analyzed, we propose that Ngn3 and Hes1 may operate as an ultradian pair in the pancreas because their expression is always mutually exclusive in the WT organ (Fig. 5E-G) and remain so in the Ngn3 TG model as well (Fig. 5H ). An ultradian model have been applied to the developing nervous system helping to explain how multipotent neural progenitors remain uncommitted when pro-neural genes are transcriptionally active (Shimojo et al., 2008; Kageyama et al., 2009; Kobayashi et al., 2009 ). An ultradian model might help explain the observed fate plasticity in the pancreas, notably when Notch signaling is active (Murtaugh et al., 2003) , but the experimental evidence would require time-lapse studies of fluorescently detectable versions of Ngn3 and Hes1, currently unavailable.
While it remains undetermined how Notch signaling causes Ngn3 protein degradation, we speculate that complex formation between bHLH factors such involving in particular Hes1, could be important. Hes1 overexpression reduces the T 1/2 of Ngn3 almost comparatively to N1ICD, or N2ICD, and we found no evidence that Skp2, as a candidate Notch-induced E3 ubiquitin ligase (Nie et al., 2008; Dohda et al., 2007) , reduced the stability of Ngn3. Importantly, Hes1 retains the ability to induce Ngn3 degradation in the presence of DN-MAML1 inhibition of Notch-induced transcriptional activation. It may be possible that Hes1-mediated transcriptional repression of unknown targets could be occurring. However, this would add an additional delay that seems incompatible with the rapid degradation kinetics of Ngn3. Therefore, it would be of interest to determine balances of possible bHLH heterodimers between, Ngn3:Hes1 (should such exist, which is currently unknown), E2A:Hes1 versus Ngn3:E2A, and testing the relative stability of such in pancreatic progenitors. A simple explanation to the observed Ngn3 degradation could be that if Ngn3 is unable to find a suitable E2A family partner then it is degraded. If so, the essential role of Notch during lateral inhibition is speculatively to control the formation of Hes1-containing bHLH complexes. In such a case, the Ngn3-based endocrine commitment hereby becomes governed through stoichiometric limitations so enforced via Notch induction of Hes1 protein.
Because Hes1 is a short-lived protein, rapid dynamic changes to the bHLH balance are achievable. The emerging model is intriguingly comparable to the now classical studies involving the balancing of bHLH complexes (Scute (aka Sisterless-B) versus E(spl) class members and Deadpan) in the X/A-based numerator/ denominator mechanism during Drosophila cell-autonomous sex determination, which controls the female activation of the splicing regulator Sxl (Liu and Belote, 1995; Cline, 1993 ) during a very narrow embryonic window.
Conclusive remarks
Towards clinical translational applications, our data is of relevance to systems in which bHLH-class factors operate to induce cell differentiation and where such are engaged during a lateral signaling process. Clearly, many such systems may exist, ranging from neural, muscle, and specific endoderm-derived structures such as pancreas and intestine, and thus encompasses cells in all germ layers. The use of particular bHLH factors in directed differentiation and/or somatic cell conversion may be viewed as a double-edged sword, as uncommitted cells are plausibly prone to respond to lateral cues and attenuate the desired cell fate induction through Notch/Hes-mediated degradation of the inducing protein. At first glance, a particular strategy would focus on providing the appropriate bHLH-type factor, together with Notch signaling inhibition. At least for the pancreatic system, this concept is problematic. The inhibition of Notch would also lead to change in compartmentalization and a loss of TrPCs. Conceptually, careful control of Notch signaling levels, as a means to appropriately define progenitor competence and the subsequently manipulate a final binary fate choice emerges as a novel strategy.
